
New scientific paper about lymphoblastic leukaemia with MLL-AF4 fusion
MLL-AF4 translocation is the genetic marker that characterises acute lymphoblastic leukaemia B (ALL-B) which is especially aggressive, commonly affects children under the age of one, and which responds poorly to treatment with chemotherapy, survival rates for this disease being less than 30%.